This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through November 3, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Analyst Blog: Archive
APP Stock Surges 89% in 6 Months: Hold for a Pullback or Buy?
by Shuvra Shankar Dey
AppLovin's 89% surge, rising revenues and expanding CTV reach spark momentum, but stretched valuations raise caution for investors.
APPNegative Net Change TTDNegative Net Change MGNIPositive Net Change
business-services tech-stocks
BALL to Boost Presence With Stake in Benepack's European Can Business
by Zacks Equity Research
Ball Corp moves to expand its European reach with an 80% stake in Benepack's can operations, strengthening its sustainable packaging network.
FLSNegative Net Change CCKPositive Net Change ADTPositive Net Change BALLPositive Net Change
industrial-products
AI-Driven Personalization Fuels SFIX's Rising AOV & RPAC in Early FY26
by Zacks Equity Research
Stitch Fix enters FY26 with accelerating AOV and RPAC as larger baskets, stronger category mix and AI-powered tools boost client spending momentum.
BOOTNegative Net Change SFIXNegative Net Change FIGSPositive Net Change BIRDNegative Net Change
retail
lululemon Surpasses Revenues & Earnings in Q3, Lifts FY25 View
by Zacks Equity Research
LULU tops Q3 revenue and EPS estimates on strong international gains, even as margins weaken and Americas results soften.
GESNegative Net Change LULUPositive Net Change CROXPositive Net Change KTBNegative Net Change
consumer-discretionary
Is Interactive Brokers a Buy as It Scales Global Market Access?
by Nikita Kataruka
IBKR's expanding global access, new markets and products, and tech-driven efficiency underscore its push to capture rising cross-border investing demand.
IBKRNegative Net Change TWNegative Net Change HOODNegative Net Change
fin-tech finance
SOFI Stock Skyrockets 82% in 6 Months: Buy, Hold or Sell?
by Shuvra Shankar Dey
SoFi's 82% surge in six months spotlights soaring profitability, record loan growth and sharply raised 2025 guidance that could keep momentum alive.
BACPositive Net Change JPMPositive Net Change SOFIPositive Net Change
fin-tech finance
DIS' OpenAI Partnership Boosts AI Footprint: Time to Hold the Stock?
by Vasundhara Sawalka
Disney's $1 billion OpenAI deal expands its AI reach and content strategy, but mixed results and segment headwinds keep the stock in hold territory.
AMZNNegative Net Change NFLXPositive Net Change DISPositive Net Change PSKYNegative Net Change
artificial-intelligence consumer-discretionary internet-content
Broadcom Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Fall
by Zacks Equity Research
AVGO posts 37% EPS growth and 28% revenue jump in fiscal Q4, fueled by AI strength, but shares slip over 3% despite the beat.
APHNegative Net Change AVGONegative Net Change AEISNegative Net Change RDDTNegative Net Change
artificial-intelligence semiconductor tech-stocks
SkyWest's EPS Estimates Northbound: Should Investors Buy the Stock?
by Zacks Equity Research
With earnings estimates soaring high, we assess the investment potential of SKYW stock currently.
DALNegative Net Change UALNegative Net Change ALKNegative Net Change SKYWNegative Net Change
airlines transportation
APPS vs. PUBM: Which Stock Has an Edge in the AdTech Market?
by Subham Roy
Digital Turbine gains momentum while PubMatic shifts strategy amid changing DSP demand and tightening AdTech dynamics.
APPSNegative Net Change PUBMNegative Net Change
ad-tech advertising
Should Investors Hold Old Dominion Stock Despite Its Higher Valuation?
by Zacks Equity Research
With ODFL's shares moving south, we assess the current positioning of the stock to determine if it's a good investment at this juncture.
JBHTNegative Net Change ODFLPositive Net Change KNXPositive Net Change
transportation
NVO Down 42% Year to Date: Is This an Indication to Sell the Stock?
by Ahan Chakraborty
Novo Nordisk stock plunges 42% so far in 2025 as GLP-1 competition, price cuts, guidance trims and restructuring plans cloud growth and elevate execution risks.
NVONegative Net Change LLYPositive Net Change VKTXNegative Net Change GPCRNegative Net Change
biotechnology biotechs medical pharmaceuticals
Can Opdivo's Label Expansions Help Bristol Myers Sustain Its Momentum?
by Zacks Equity Research
BMY gets a priority FDA review for Opdivo's use in previously untreated advanced Hodgkin lymphoma, reinforcing its oncology momentum.
RHHBYPositive Net Change BMYPositive Net Change MRKPositive Net Change
biotechnology biotechs medical pharmaceuticals
Can Tesla's New Discounts on Model Y Help Boost Q4 Deliveries?
by Zacks Equity Research
TSLA's year-end discounts, free upgrades and 0% financing aim to lift Model Y demand as the company works to clear inventory and sustain momentum.
TSLAPositive Net Change NIONegative Net Change XPEVNegative Net Change
auto-tires-trucks electric-vehicles
Synopsys Q4 Earnings Surpass Estimates, Revenues Rise Y/Y
by Zacks Equity Research
SNPS posts a Q4 beat as revenues surge on strong Time-Based, Upfront Product and EDA growth, while offering upbeat FY26 and Q1 outlooks.
APHNegative Net Change NVDANegative Net Change SNPSNegative Net Change COMMNegative Net Change
tech-stocks
Daktronics' Q2 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Fall
by Zacks Equity Research
DAKT tops Q2 estimates with strong earnings and revenue growth, boosted by rising orders and a surging product backlog.
APHNegative Net Change AEISNegative Net Change DAKTNegative Net Change APPSNegative Net Change
earnings tech-stocks
ATRC Treats First Patients Using Novel Dual-Energy PFA-RFA Platform
by Zacks Equity Research
AtriCure's first patients treated with its dual-energy PFA-RFA platform mark a key step as it moves toward a clinical trial next year.
BSXPositive Net Change ISRGNegative Net Change ATRCPositive Net Change MEDPNegative Net Change
medical medical-devices
Kymera's Eczema Drug Gets Fast Track Designation in the United States
by Zacks Equity Research
KYMR gains momentum as the FDA grants Fast Track to KT-621 for moderate to severe atopic dermatitis, boosting the stock and advancing its Type 2 pipeline.
SNYNegative Net Change GILDNegative Net Change KYMRPositive Net Change
biotechnology biotechs medical pharmaceuticals
Can Verizon's Empower Field Network Infrastructure Upgrade Aid Shares?
by Zacks Equity Research
VZ's Wi-Fi 6E upgrade at Empower Field boosts fan connectivity with 2,400 new access points and a faster, safer stadium network.
TPositive Net Change VZPositive Net Change TMUSNegative Net Change
internet iot mobile tech-stocks
Clorox's Brand Investments Are Up: Will They Translate to Growth?
by Zacks Equity Research
CLX leans on heavier brand investment and new product launches to rebuild momentum as ERP-related disruptions weigh on near-term sales.
COCOPositive Net Change CLXPositive Net Change UNFIPositive Net Change LWPositive Net Change
consumer-staples
DraftKings' iGaming Up 25%: A Second Growth Engine Emerging?
by Harendra Ray
DKNG's 25% iGaming surge signals a steadier growth engine as upgrades and stronger customer metrics lift third-quarter momentum.
MGMNegative Net Change DKNGPositive Net Change FLUTPositive Net Change
consumer-discretionary
Is Comfort Systems Positioned for Long-Term Pharma Project Demand?
by Amit Kr Ram
FIX sees rising pharma and life sciences planning activity, signaling a strong long-term pipeline for its specialized mechanical and electrical work.
WSONegative Net Change AAONNegative Net Change FIXNegative Net Change TGENNegative Net Change
construction
Can Flex Offset Automotive Headwinds in Its Reliability Segment?
by Vaishali Doshi
FLEX leans on data center surge to counter automotive softness in its Reliability segment's performance.
JBLNegative Net Change FLEXNegative Net Change CLSNegative Net Change
tech-stocks
Can PLAY's Revamped Remodel Blueprint Catalyze Its Next Growth Cycle?
by Mrithunjoy Kaushik
Dave & Buster's sharpens its remodel strategy with guest-first upgrades, aiming to boost traffic, productivity and fuel its Back to Basics momentum.
EATPositive Net Change QSRPositive Net Change PLAYNegative Net Change
restaurants retail
Suncor Unveils 2026 Guidance Focused on Growth & Superior Returns
by Zacks Equity Research
SU's 2026 guidance outlines higher production, strong refining utilization and a stronger commitment to shareholder returns backed by disciplined investments.
SUPositive Net Change CVEPositive Net Change NGSNegative Net Change BTENegative Net Change
energy oil-energy